Counting embryonic and induced pluripotent stem cells on route to treating diabetes

In this whitepaper, ChemoMetec demonstrates how the technology of the NucleoCounter^® NC-202™ automated cell counter can be used to count and monitor cells during β-cell generation accurately and precisely. Additionally, showing that the aggregated cell count assay enables a robust and precise solution to the challenge of counting highly aggregated β-cell clusters.